Breaking News Instant updates and real-time market news.

MODN

Model N

$18.40

0.15 (0.82%)

16:31
08/07/18
08/07
16:31
08/07/18
16:31

Model N sees Q4 adjusted EPS (3c)-(1c), consensus (1c)

Sees Q4 revenue $35.2M-$35.7M, consensus $35.62M.

  • 07

    Aug

  • 20

    Aug

  • 21

    Aug

  • 06

    Sep

MODN Model N
$18.40

0.15 (0.82%)

12/12/17
JPMS
12/12/17
DOWNGRADE
Target $18
JPMS
Neutral
Model N downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Sterling Auty downgraded Model N to Neutral with an unchanged price target of $18 in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. As such, he's moderating his bullish outlook into next year.
02/07/18
JMPS
02/07/18
UPGRADE
JMPS
Outperform
Model N upgraded to Outperform from Market Perform at JMP Securities
JMP Securities analyst Patrick Walravens upgraded Model N to Outperform with a $20 price target following the strong Q1 report and guidance. The analyst expects further share upside to be driven by economic benefits of an increasingly recurring model, completion of Revitas integration, making Model N a bigger player in a less crowded market, positive free cash flow next quarter and for the rest of the year, and improved profitability should provide the company options to refinance its $50M in term debt at a lower rate.
03/14/18
JPMS
03/14/18
NO CHANGE
Target $20
JPMS
Neutral
Model N price target raised to $20 at JPMorgan after investor day
JPMorgan analyst Jackson Ader raised his price target on Model N to $20 from $18 after the company's investor day provided some color around its near and long term opportunities. Ader notes the FY19 targets imply a recurring revenue growth of 15% and margins were ahead of his estimates. The analyst keeps his Neutral rating however, adding that the near-doubling of the stock price since late 2016 has brought valuation to appropriate levels, with further outperformance "harder to come by".
07/18/18
NEED
07/18/18
INITIATION
Target $23
NEED
Buy
Model N initiated with a Buy at Needham
Needham analyst Ryan MacDonald initiated Model N with a Buy and $23 price target saying it is the clear market leader in revenue management software in the Life Sciences vertical. MacDonald views Model N's discounted valuation as an attractive buying opportunity ahead the transition of on-premise customers and resulting revenue uplift, up-sell to existing base, and new customer adoption that will drive 15% sustainable revenue growth.

TODAY'S FREE FLY STORIES

BASFY

BASF

$0.00

(0.00%)

09:10
06/27/19
06/27
09:10
06/27/19
09:10
Hot Stocks
BASF announces restructuring, to cut 6,000 positions by end of 2021 »

BASF announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

09:10
06/27/19
06/27
09:10
06/27/19
09:10
General news
U.S. equities have trimmed overnight gains »

U.S. equities have…

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

, TEX

Terex

$30.76

-0.245 (-0.79%)

09:09
06/27/19
06/27
09:09
06/27/19
09:09
Hot Stocks
ASV Holdings enters definitive merger agreement with Yanmar affiliate »

ASV Holdings (ASV)…

ASV

ASV Holdings

$1.64

-0.11 (-6.29%)

TEX

Terex

$30.76

-0.245 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.21

-1.01 (-1.83%)

09:08
06/27/19
06/27
09:08
06/27/19
09:08
Hot Stocks
Mondelez announces renewable energy partnership with Enel Green Power »

Mondelez International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$2.01

-0.49 (-19.60%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07
Recommendations
Pareteum analyst commentary at Lake Street »

Pareteum fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 17

    Jul

  • 12

    Sep

LUNA

Luna Innovations

$4.26

0.06 (1.43%)

, HSC

Harsco

$27.13

0.54 (2.03%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07
Conference/Events
Singular Research to hold a conference »

Summer Solstice New York…

LUNA

Luna Innovations

$4.26

0.06 (1.43%)

HSC

Harsco

$27.13

0.54 (2.03%)

DAKT

Daktronics

$5.99

(0.00%)

ACU

Acme United

$21.20

-0.62 (-2.84%)

CMTL

Comtech

$28.00

0.52 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 12

    Sep

BASFY

BASF

$0.00

(0.00%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07
Hot Stocks
Breaking Hot Stocks news story on BASF »

BASF announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

BSQR

Bsquare Corp

$1.23

-0.01 (-0.81%)

09:06
06/27/19
06/27
09:06
06/27/19
09:06
Hot Stocks
Bsquare Corp selected by Arcus FM in the U.K. »

Bsquare announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMP

Adamis Pharmaceuticals

$1.29

0.03 (2.38%)

09:05
06/27/19
06/27
09:05
06/27/19
09:05
Hot Stocks
Adamis Pharmaceuticals files two motions, lawsuit in response to kaleo suit »

Adamis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

FDX

FedEx

$159.92

3.92 (2.51%)

09:04
06/27/19
06/27
09:04
06/27/19
09:04
Recommendations
FedEx analyst commentary  »

FedEx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

OSTK

Overstock.com

$13.54

2.765 (25.66%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Overstock.com subsidiary tZERO launches crypto wallet mobile app »

Overstock.com announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$18.98

-0.36 (-1.86%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Yext and Hootsuite launch platform integration for customer reviews »

Yext announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

YEXT

Yext

$18.98

-0.36 (-1.86%)

09:03
06/27/19
06/27
09:03
06/27/19
09:03
Hot Stocks
Yext and Hootsuite launch platform integration for customer reviews »

Yext announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

F

Ford

$9.90

0.06 (0.61%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Hot Stocks
Ford to cut 12,000 jobs in Europe by end of 2020 »

Ford said in a statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 24

    Jul

  • 23

    Oct

VBLT

VBL Therapeutics

$1.17

-0.01 (-0.85%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Initiation
VBL Therapeutics initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

09:01
06/27/19
06/27
09:01
06/27/19
09:01
Hot Stocks
Ovid Therapeutics expects interim data from ENDYMION trial in Q3 »

Ovid continues to enroll…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

09:00
06/27/19
06/27
09:00
06/27/19
09:00
Hot Stocks
Ovid Therapeutics expects Phase 2 ROCKET trial results year-end or early 2020 »

The Phase 2 ROCKET trial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
06/27/19
06/27
09:00
06/27/19
09:00
General news
Treasury Action: the markets were little changed on the data »

Treasury Action: the…

09:00
06/27/19
06/27
09:00
06/27/19
09:00
General news
The 10k initial claims rise to 227k »

The 10k initial claims…

08:59
06/27/19
06/27
08:59
06/27/19
08:59
Conference/Events
Senate Banking, Housing & Urban Affairs Committee to hold a hearing »

The Committee holds a…

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:59
06/27/19
06/27
08:59
06/27/19
08:59
Hot Stocks
Ovid Therapeutics plans to enroll patients in Phase 3 NEPTUNE trial in Q3 »

Following an End-of-Phase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$9.45

-0.03 (-0.32%)

08:59
06/27/19
06/27
08:59
06/27/19
08:59
Recommendations
AMC Entertainment analyst commentary at Barrington »

AMC Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFI

Infinity Pharmaceuticals

$1.68

0.01 (0.60%)

08:58
06/27/19
06/27
08:58
06/27/19
08:58
Initiation
Infinity Pharmaceuticals initiated  »

Oppenheimer bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAGE

WageWorks

$51.65

0.91 (1.79%)

, HQY

HealthEquity

$62.16

-2.5 (-3.87%)

08:58
06/27/19
06/27
08:58
06/27/19
08:58
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS:…

WAGE

WageWorks

$51.65

0.91 (1.79%)

HQY

HealthEquity

$62.16

-2.5 (-3.87%)

WBA

Walgreens Boots Alliance

$52.40

-0.59 (-1.11%)

KBH

KB Home

$23.58

-0.24 (-1.01%)

OFG

OFG Bancorp

$20.68

0.305 (1.50%)

NVAX

Novavax

$5.52

-0.08 (-1.43%)

CAG

Conagra Brands

$28.94

0.035 (0.12%)

MKC

McCormick

$150.58

-2.545 (-1.66%)

PDCO

Patterson Companies

$24.90

0.7 (2.89%)

PIR

Pier 1 Imports

$8.80

0.14 (1.62%)

RAD

Rite Aid

$7.11

0.26 (3.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 17

    Jul

08:58
06/27/19
06/27
08:58
06/27/19
08:58
Conference/Events
Jefferies to hold a summit »

Private Company Frac Sand…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.